Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robert Naeije (BRUSSELS, Belgium). Pathophysiology of pulmonary hypertension: what the interested clinician needs to know. ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease

Member's Comments

No comment yet.

Related content which might interest you: Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Assessing risk in pulmonary arterial hypertension: what we know, what we don't Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017 Year: 2017 Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet? Source: Eur Respir Rev 2014; 23: 458-468 Year: 2014 Update on severe asthma: what we know and what we need Source: Eur Respir Rev 2009; 18: 58-65 Year: 2009 Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go? Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously! Year: 2019 Challenges in pulmonary hypertension: managing the unexpected Source: Eur Respir Rev 2015; 24: 674-681 Year: 2015 Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014 Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021 Year: 2021 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 Pulmonary hypertension: what does the pathology tell us? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 What's it like to live with idiopathic pulmonary fibrosis? Ask the experts Source: Eur Respir J 2016; 47:1324-1326 Year: 2016 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing? Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019 Year: 2019 Making the diagnosis of acute pulmonary embolism: what do the guidelines say? Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020